s6y

Cellectis S.A.

Ticker
CLLS
CIK
1627281
Industry
Biological Products, (No Diagnostic Substances)

Ownership 45

  1. SC 13D/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D/A Major Shareholders
  7. SC 13D Major Shareholders
  8. SC 13D/A Major Shareholders
  9. SC 13D/A Major Shareholders
  10. SC 13G/A Major Shareholders

All 45 ownership filings

Prospectus 32

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 32 prospectus filings

Other 461

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. SCHEDULE 13D/A
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K/A Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 461 other filings